Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study - Concepedia

Concepedia

Publication | Open Access

Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study

DOI Full Paper Access

115

Citations

18

References

2006

Year

Gerhild Becker, Hans‐Peter Allgaier, Manfred Olschewski, Andreas Zähringer, Hubert E. Blum

Abstract

The randomized controlled double-blind HECTOR trial showed no survival benefit for HCC patients treated with long-acting octreotide compared with placebo.

References

	Year	Citations

Page 1